Retour sur lavenir.net
   FAGRON 23.900 € (+0,42 %)     PROXIMUS 6.630 € (-0,30 %)     AB INBEV 62.120 € (-0,74 %)     RETAIL ESTATES 69.400 € (-0,57 %)     WDP 23.920 € (+0,17 %)     ARGENX SE 678.400 € (-1,17 %)     BIOTALYS 2.230 € (-2,41 %)     KINEPOLIS GROUP 29.950 € (-1,48 %)     BANQUP GROUP 2.590 € (-5,47 %)     CARE PROPERTY INV. 12.800 € (-0,16 %)     NEXTENSA 46.450 € (-0,04 %)     FLUXYS BELGIUM D 21.400 € (-0,47 %)     BQUE NAT. BELGIQUE 398.000 € (-0,25 %)     CMB.TECH 10.820 € (-3,91 %)     SYENSQO 55.350 € (-0,63 %)     AEDIFICA 73.700 € (+0,14 %)     UCB 243.100 € (-1,62 %)     VAN DE VELDE 32.300 € (-0,62 %)     KBC 115.450 € (-1,95 %)     AZELIS GROUP 10.390 € (+0,29 %)     ENERGYVISION 13.300 € (0,00 %)     D'IETEREN GROUP 180.000 € (-1,48 %)     TESSENDERLO 21.250 € (+0,71 %)     NYXOAH 2.790 € (-0,36 %)     CFE 11.200 € (-0,88 %)     EXMAR 10.800 € (+0,47 %)     DECEUNINCK 2.130 € (-2,07 %)     SIPEF 97.100 € (+2,21 %)     XIOR 27.500 € (-0,54 %)     SEQUANA MEDICAL 0.530 € (+1,53 %)     UMICORE 17.380 € (-1,25 %)     ORANGE BELGIUM 20.500 € (0,00 %)     AGFA-GEVAERT 0.482 € (-1,13 %)     TITAN S.A. 46.420 € (-0,68 %)     ECONOCOM GROUP 1.490 € (+0,34 %)     SHURGARD 27.550 € (-1,08 %)     BPOST 1.884 € (+0,11 %)     ONTEX GROUP 2.970 € (-2,30 %)     WAREHOUSES ESTATES 42.000 € (+1,20 %)     HOME INVEST BE. 19.140 € (-0,10 %)     COFINIMMO 86.300 € (+0,06 %)     BREDERODE 103.400 € (-0,19 %)     ACKERMANS V.HAAREN 276.400 € (-1,00 %)     CENERGY 20.680 € (-2,27 %)     BIOSENIC 0.002 € (-8,33 %)     BEKAERT 41.650 € (-0,48 %)     AGEAS 68.050 € (-0,80 %)     VIOHALCO 14.300 € (-1,38 %)     SOFINA 223.400 € (-1,15 %)     VGP 92.300 € (-0,32 %)     VASTNED 30.450 € (+1,16 %)     TUBIZE-FIN 209.000 € (-2,70 %)     SOLVAC NOM(RETAIL) 74.000 € (0,00 %)     LOTUS BAKERIES 10 000.000 € (+0,60 %)     GIMV 48.500 € (-0,31 %)     GBL 80.200 € (-0,62 %)     IBA 14.280 € (-0,83 %)     BARCO 9.335 € (-0,95 %)     ONWARD MEDICAL 3.005 € (+3,44 %)     COLRUYT 33.300 € (+0,48 %)  
   STMICROELECTRONICS 37.460 € (-0,40 %)     ESSILORLUXOTTICA 201.500 € (-2,52 %)     GECINA 72.200 € (-0,28 %)     KERING 238.100 € (-2,10 %)     DASSAULT AVIATION 304.800 € (-2,25 %)     CEGEDIM 12.150 € (+0,41 %)     ORANGE 17.360 € (-1,62 %)     ATOS 35.560 € (-1,88 %)     THALES 242.000 € (-2,30 %)     HEINEKEN HOLDING 62.000 € (+0,08 %)     Vusion 123.500 € (+3,96 %)     WORLDLINE 0.308 € (+0,42 %)     ARVERNE GROUP 5.800 € (+1,40 %)     CSG 20.310 € (-3,47 %)     AIRBUS 166.240 € (-2,51 %)     FDJ UNITED 24.310 € (-7,95 %)     BIOMERIEUX 88.750 € (-2,04 %)     2CRSI 41.980 € (+3,09 %)     AHOLD DEL 41.640 € (+0,34 %)     EXPLOSIFS PROD.CHI 275.000 € (+5,77 %)     LOUIS HACHETTE 1.689 € (-2,43 %)     VIRBAC 379.500 € (-1,17 %)     HAVAS 16.300 € (+0,62 %)     AXA 41.440 € (-2,31 %)     SES 6.560 € (+3,23 %)     PLANISWARE 18.620 € (-0,43 %)     DELFINGEN 30.000 € (-1,64 %)     ASML HOLDING 1 249.800 € (+1,03 %)     ADOCIA 4.736 € (-17,20 %)     SOCIETE GENERALE 70.370 € (-1,94 %)     JCDECAUX 19.140 € (-0,47 %)     TF1 6.795 € (-0,51 %)     S.E.B. 48.760 € (-0,49 %)     MERCIALYS 12.640 € (-0,16 %)     CAPGEMINI 106.750 € (-2,51 %)     ING GROEP N.V. 24.150 € (-1,41 %)     VIRIDIEN 150.700 € (+5,53 %)     APERAM 41.380 € (-0,53 %)     AALBERTS NV 31.340 € (-0,32 %)     ALFEN 11.930 € (+6,33 %)     NEXANS 135.500 € (-0,15 %)     SAINT GOBAIN 76.920 € (-1,91 %)     RELX 31.580 € (-1,31 %)     UNILEVER 48.610 € (-0,20 %)     VALLOUREC 24.590 € (+3,80 %)     KPN KON 4.626 € (+0,19 %)     UMG 20.010 € (-0,35 %)     SCOR SE 32.420 € (-1,58 %)     SARTORIUS STED BIO 184.000 € (-2,39 %)     ARKEMA 61.900 € (+0,49 %)     ALLFUNDS GROUP 8.775 € (+0,29 %)     INPOST 15.200 € (-0,33 %)     ASR NEDERLAND 63.640 € (-0,59 %)     PUBLICIS GROUPE SA 78.480 € (-0,38 %)     HERMES INTL 1 645.500 € (-1,82 %)     SHELL PLC 38.010 € (+0,84 %)     FORVIA 10.210 € (-1,26 %)     BE SEMICONDUCTOR 232.300 € (+1,93 %)     DANONE 68.080 € (+2,50 %)     NN GROUP 73.640 € (-0,16 %)  
News Réglementées
22/04/2026 09:15

Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

EQS-News: Redcare Pharmacy N.V. / Key word(s): Miscellaneous
Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

22.04.2026 / 09:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

Sevenum, Netherlands, April 22, 2026. Redcare Pharmacy’s B2B access to the telematics infrastructure (TI) is now significantly improved through the use of a new technology and identity solution from partners ehex and D-Trust (Bundesdruckerei). The previously required physical institutional card is being replaced by a fully digital identity of the pharmacy within the TI gateway. This is also noticeable for customers via their B2C access: access to e-prescriptions via CardLink remains unchanged in terms of process but becomes faster overall and reduces waiting times.

The transition to the so-called HSM-B technology marks a technological advancement in the ongoing development of the telematics infrastructure. It significantly improves speed, stability and scalability of the connection, while also enabling a more efficient cost structure. This creates an important foundation for further growth in the e-prescription segment.

Customers benefit from measurable improvements in the e-prescription process: after the CardLink step, prescriptions can be retrieved and processed more quickly from the gematik server. This reduces waiting times in the Rx ordering process and noticeably improves performance when redeeming e-prescriptions.

The new solution is part of the next expansion stage of the TI architecture within the framework of gematik TI 2.0. It addresses increasing demands for speed and scalability in the digital healthcare market. The rollout begins with a test phase together with ehex as well as additional partners and will serve as the basis for a subsequent broader rollout.

Lode Fastré, CIO of Redcare Pharmacy: “The introduction of this technology is an important step in further scaling our e-prescription business. It improves the performance of our systems and lays the foundation for future growth. At the same time, it underlines our leading role in connecting to the TI infrastructure.”

___

About Redcare Pharmacy.

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Pilsen, Settala (Milan), Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers over 14.2 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

 

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.



22.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone:0800 - 200 800 300
Fax:0800 - 90 70 90 20
E-mail:investors@redcare-pharmacy.com
Internet:www.redcare-pharmacy.com
ISIN:NL0012044747, DE000A19Y072
WKN:A2AR94, A19Y072
Indices:MDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
EQS News ID:2311150

 
End of NewsEQS News Service

2311150  22.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière